BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 26853880)

  • 1. Epigenetic suppression of iNOS expression in human endothelial cells: A potential role of Ezh2-mediated H3K27me3.
    Dreger H; Ludwig A; Weller A; Baumann G; Stangl V; Stangl K
    Genomics; 2016 Apr; 107(4):145-9. PubMed ID: 26853880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic regulation of cell adhesion and communication by enhancer of zeste homolog 2 in human endothelial cells.
    Dreger H; Ludwig A; Weller A; Stangl V; Baumann G; Meiners S; Stangl K
    Hypertension; 2012 Nov; 60(5):1176-83. PubMed ID: 22966008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flow-dependent epigenetic regulation of IGFBP5 expression by H3K27me3 contributes to endothelial anti-inflammatory effects.
    Xu S; Xu Y; Yin M; Zhang S; Liu P; Koroleva M; Si S; Little PJ; Pelisek J; Jin ZG
    Theranostics; 2018; 8(11):3007-3021. PubMed ID: 29896299
    [No Abstract]   [Full Text] [Related]  

  • 4. Enhancer of zeste homolog 2-catalysed H3K27 trimethylation plays a key role in acute-on-chronic liver failure via TNF-mediated pathway.
    Zhou T; Sun Y; Li M; Ding Y; Yin R; Li Z; Xie Q; Bao S; Cai W
    Cell Death Dis; 2018 May; 9(6):590. PubMed ID: 29789597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancer of zeste homolog-2 (EZH2) methyltransferase regulates transgelin/smooth muscle-22α expression in endothelial cells in response to interleukin-1β and transforming growth factor-β2.
    Maleszewska M; Gjaltema RA; Krenning G; Harmsen MC
    Cell Signal; 2015 Aug; 27(8):1589-96. PubMed ID: 25917318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crosstalk Between Histone and DNA Methylation in Regulation of Retinal Matrix Metalloproteinase-9 in Diabetes.
    Duraisamy AJ; Mishra M; Kowluru RA
    Invest Ophthalmol Vis Sci; 2017 Dec; 58(14):6440-6448. PubMed ID: 29261844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EZH2-Mediated H3K27me3 Is Involved in Epigenetic Repression of Deleted in Liver Cancer 1 in Human Cancers.
    Au SL; Wong CC; Lee JM; Wong CM; Ng IO
    PLoS One; 2013; 8(6):e68226. PubMed ID: 23826380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EZH2 promotes invasion and metastasis of laryngeal squamous cells carcinoma via epithelial-mesenchymal transition through H3K27me3.
    Luo H; Jiang Y; Ma S; Chang H; Yi C; Cao H; Gao Y; Guo H; Hou J; Yan J; Sheng Y; Ren X
    Biochem Biophys Res Commun; 2016 Oct; 479(2):253-259. PubMed ID: 27638307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intermittent High Glucose Elevates Nuclear Localization of EZH2 to Cause H3K27me3-Dependent Repression of KLF2 Leading to Endothelial Inflammation.
    Thakar S; Katakia YT; Ramakrishnan SK; Pandya Thakkar N; Majumder S
    Cells; 2021 Sep; 10(10):. PubMed ID: 34685528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic silencing of microRNA-218 via EZH2-mediated H3K27 trimethylation is involved in malignant transformation of HBE cells induced by cigarette smoke extract.
    Wang B; Liu Y; Luo F; Xu Y; Qin Y; Lu X; Xu W; Shi L; Liu Q; Xiang Q
    Arch Toxicol; 2016 Feb; 90(2):449-61. PubMed ID: 25526925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of Ezh2 In Vitro and the Decline of
    Hong F; Zhao M; Zhang L; Feng L
    Stem Cells Dev; 2019 May; 28(10):649-658. PubMed ID: 30887911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interplay of miR-137 and EZH2 contributes to the genome-wide redistribution of H3K27me3 underlying the Pb-induced memory impairment.
    Gu X; Xu Y; Xue WZ; Wu Y; Ye Z; Xiao G; Wang HL
    Cell Death Dis; 2019 Sep; 10(9):671. PubMed ID: 31511494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AGE-Induced Suppression of EZH2 Mediates Injury of Podocytes by Reducing H3K27me3.
    Liebisch M; Wolf G
    Am J Nephrol; 2020; 51(9):676-692. PubMed ID: 32854097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Yin Yang 1-mediated epigenetic silencing of tumour-suppressive microRNAs activates nuclear factor-κB in hepatocellular carcinoma.
    Tsang DP; Wu WK; Kang W; Lee YY; Wu F; Yu Z; Xiong L; Chan AW; Tong JH; Yang W; Li MS; Lau SS; Li X; Lee SD; Yang Y; Lai PB; Yu DY; Xu G; Lo KW; Chan MT; Wang H; Lee TL; Yu J; Wong N; Yip KY; To KF; Cheng AS
    J Pathol; 2016 Apr; 238(5):651-64. PubMed ID: 26800240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Polycomb Group Protein EZH2 Impairs DNA Damage Repair Gene Expression in Human Uterine Fibroids.
    Yang Q; Nair S; Laknaur A; Ismail N; Diamond MP; Al-Hendy A
    Biol Reprod; 2016 Mar; 94(3):69. PubMed ID: 26888970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Novel EZH2 Targets Regulating Osteogenic Differentiation in Mesenchymal Stem Cells.
    Hemming S; Cakouros D; Vandyke K; Davis MJ; Zannettino AC; Gronthos S
    Stem Cells Dev; 2016 Jun; 25(12):909-21. PubMed ID: 27168161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CLDN14 is epigenetically silenced by EZH2-mediated H3K27ME3 and is a novel prognostic biomarker in hepatocellular carcinoma.
    Li CP; Cai MY; Jiang LJ; Mai SJ; Chen JW; Wang FW; Liao YJ; Chen WH; Jin XH; Pei XQ; Guan XY; Zeng MS; Xie D
    Carcinogenesis; 2016 Jun; 37(6):557-566. PubMed ID: 27207647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of EZH2-mediated H3K27me3 in placental ADAM12-S expression: implications for fetoplacental growth.
    Zhu YN; Gan XW; Pan F; Ni XT; Myatt L; Wang WS; Sun K
    BMC Med; 2022 May; 20(1):189. PubMed ID: 35610640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant overexpression of EZH2 and H3K27me3 serves as poor prognostic biomarker for esophageal squamous cell carcinoma patients.
    Liu F; Gu L; Cao Y; Fan X; Zhang F; Sang M
    Biomarkers; 2016; 21(1):80-90. PubMed ID: 26631178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome-wide ChIP-seq analysis of EZH2-mediated H3K27me3 target gene profile highlights differences between low- and high-grade astrocytic tumors.
    Sharma V; Malgulwar PB; Purkait S; Patil V; Pathak P; Agrawal R; Kulshreshtha R; Mallick S; Julka PK; Suri A; Sharma BS; Suri V; Sharma MC; Sarkar C
    Carcinogenesis; 2017 Feb; 38(2):152-161. PubMed ID: 27993893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.